Marketresearchnews

Tuesday, 6 October 2020

MEA Anti-fungal agents Market Positive Growth And Forecasts By 2022

Middle East and Africa Anti-fungal agents Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Market research future published a half-cooked research report on Middle East and Africa Anti-fungal agents market. The Middle East and Africa Anti-fungal agents market is expected to grow at a CAGR of 3.5% during the period 2016 to 2022.

Anti-fungal agents are used in the treatment of infections caused by fungus. According to global action fund for fungal infection, globally, over 300 million people of all ages suffer from a serious fungal infection every year. The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.

Also Read : https://www.abnewswire.com/pressreleases/middle-east-and-africa-antifungal-agents-market-to-reach-around-285-billion-by-2022_178110.html

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of block buster drugs. Over the counter drugs are an important reasons for the growth of anti-fungal agents market.

The Middle East and Africa anti-fungal agents market is segmented into therapeutic indication which is further segmented into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class the sub-segments are azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. By route of administration the market is further divided into oral, local and others.

Key Players:

The major participants of this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others

Middle East and Africa Anti-Fungal Agents Market:

The Middle East and Africa Anti-fungal agents market has been evaluated as a growing market and it is expected that the market will grow at a moderate CAGR in future. The Middle East and Africa Anti-fungal agents market is expected to grow with CAGR of ~3.5% during the forecast period. The growth will be primary channeled by the need of unmet medical needs, rising incomes of the population and the high prevalence of fungal infection in Africa. Environmental factors such as high humidity and temperature along with the rich biodiversity of Africa will positively affect the market growth of anti-fungal agents.

Regional Analysis:

Depending on geographic region, anti-fungal agents market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. However the future market will be led by the poor developed parts of Africa due to large unmet needs and the seasonal climatic conditions of Africa. The eastern parts of Africa is expected to have greater market share as compared to the hot and dry western coast.

Segmentation:

Middle East and Africa anti-fungal agents market has been segmented on the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. On the basis of route of administration; market is segmented into oral, local and others.

Among the infections Dermatophytosis holds the majority share followed by candidiasis. The market leaders with considerable sales include fluconazole, terbinafine, voriconazole, itraconazole, and caspofungin.

Study Objectives Middle East and Africa Anti-Fungal Agents Market:

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa anti-fungal agents market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa anti-fungal agents market
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by product type, by construction material, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

The report for Middle East and Africa Anti-fungal agents Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/mea-anti-fungal-agents-market-2582

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Menstrual Cup Market Expected Tremendous Growth Till 2023

Global Menstrual Cup Market research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

The Menstrual Cup – Is it Efficient?

Although menstruation still remains a taboo and stigma in many parts of the world, technological advancements, research, and awareness regarding the acceptance of menstruation along with developing healthy sanitary tools for women have led to the broader use of the menstrual cup. Even though it was invented in 1937 by an American actress, the mainstream usage, and safer usage of the menstrual cup has grown relatively recently.

A menstrual cup is a small, flexible, cup-like structure made of silicone or latex rubber, and is used feminine hygiene product to catch and collect a woman’s flow instead of absorbing it like a pad or tampon. Depending on the quantity of flow, the cup is removed, cleared, cleaned, and reinserted after every four-twelve hours. It may be reusable or disposable; the reusable cups need to be sterilized in boiling water before use.

Also Read : https://www.medgadget.com/2020/02/menstrual-cup-market-to-garner-usd-1514-01-million-is-expected-to-exhibit-a-3-50-cagr-by-2023-global-industry-size-share-challenges-growth-future-demands-trends.html

Advantages

Cost-effective, Long term, hygienic and environmentally friendly

Menstrual cups are a cost-efficient form of menstrual sanitation product, especially for underprivileged women in developing and under-developed countries who do not have access to affordable sanitary products.

There are multiple inadequate, unhygienic methods used by these women, which have increased the prevalence of infections and diseases. Additionally, tampons are prone to the risk of toxic shock syndrome, which is a form of a severe, potentially fatal bacterial infection, when a tampon is worn for longer than eight hours, and sanitary pads cause chafing and leak sometimes. In comparison, the menstrual cup is a healthier, more comfortable, durable, and long-term method of menstrual sanitation.

Technological advancements have led to most menstrual cups in the market to be reusable. Thus, the menstrual cup is an effective measure to reduce solid waste. Menstrual cups do not contribute to daily waste, and the amount of disposed of packaging is also reduced. Disposable sanitary tools such as tampons and pads have been observed to contribute majorly to the solid waste globally. Scientists have declared that some pads and tampons may take up to 25 years to break down in the ocean, and 50 or more years on land due to the plastic content.

This makes the menstrual cup a sustainable choice in present times,where the environmental concerns are incredibly high.

Menstrual Cup Market Summary

Market Research Future (MRFR) has announced the release of a new report on the global menstrual cup market. The report analyzes the global menstrual cup market from top to bottom and comes up with actionable insights in terms of the leading segments of the menstrual cup market, key players in the menstrual cup market, and the major drivers and restraints affecting the market. The trajectory of the global menstrual cup market over the forecast period is projected in the report with the help of present and past statistics about the menstrual cup market. Key strategies likely to benefit the market players in capturing a larger share of the menstrual cup market are also profiled in the report. According to the report, the global menstrual cup market is expected to rise at a CAGR of 3.5% over the forecast period (2018-2023).

Menstrual cups are a feminine hygiene product increasingly being used in place of tampons or sanitary napkins. The cup is bell-shaped and seals against the vaginal wall just below the cervix. Instead of absorbing the menstrual fluid like tampons or sanitary napkins, menstrual cups store menstrual fluid for later removal. This makes them reusable, which has become the major driver for the menstrual cup market. The high prices of tampons and sanitary pads, as well as the need to keep replacing them at regular intervals, have made menstrual cups a highly attractive alternative. Although the initial cost of menstrual cups is higher than tampons or sanitary napkins, in the longer run, they become immensely cheaper than the latter. The menstrual cup market has also used the better environmental feasibility of menstrual cups as a selling point, as less waste is generated from the use of menstrual cups than sanitary napkins.

Menstrual Cup Market Segmentation:

By product, the menstrual cup market has been segmented into reusable and disposable menstrual cups. Reusable cups are likely dominate the market by accounting for a large market share by 2023. Reusable menstrual cups can be used for up to 5 years, depending on the specific brand.

By type, the market is segmented into hollow, pointy, flat, and round. The round segment accounted for 43% market share due to the flexibility in the design of these products.

By distribution channel, the market is segmented into online stores, retail outlets, and others. The online store channel segment accounted for 62% market share owing to penetration of e-commerce stores and changing buying patterns of consumers.

Menstrual Cup Market Regional Analysis:

The global menstrual cup market is segmented geographically into the Americas, Europe, Asia Pacific, and the Middle East and Africa. North America and Europe are likely to dominate the global menstrual cup market over the forecast period due to the widespread awareness about the importance of feminine hygiene products and the increasing popularity of reusable and convenient methods of maintaining feminine hygiene.

The Asia Pacific market is likely to hold a smaller share than these two dominant markets, as awareness regarding menstruation and feminine hygiene products is quite low in some regions of Asia Pacific. While urban centers in advanced APAC countries such as Australia, China, India, Indonesia, Singapore, and Malaysia are relatively more open to the sale of feminine hygiene product, a large share of the female population doesn’t have access to sanitary products. Product advancement in the feminine hygiene product market is consequently lacking, leading to a lack of awareness about menstrual cups. This is likely to hold back the menstrual cup market in Asia Pacific over the forecast period.

The Middle East and Africa is likely to retain the lowest share in the global menstrual cup market over the forecast period due to the lack of awareness about feminine hygiene products in the region.

Menstrual Cup Market Competitive Landscape:

The leading players in the global menstrual cup market include Me Luna, Ruby Life Ltd., Irisana SA, Vcup, FemCap Inc., LadyCup, Lunette, The Keeper Inc., Anigan, and Diva International Inc.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/menstrual-cup-market-1407

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Ureteral Stents Market Expected Tremendous Growth Till 2025

The exclusive research report on the Global Ureteral Stents Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

Global Ureteral Stents Market Research Report, by Types (Open end stents, double pigtail stents, closed end stents, multiloop stents), by material (Metal stents, Silicone stents, Plastic stents, Hydrogel stents, Polyurethane stents and other), by application (ureterorenoscopy, lithotripsy and other) – Forecast Till 2023.

Market Synopsis:

Ureteral stents are developed for treating obstructions in urinary flow. A lot of factors result in abnormal functioning of the kidney, which is likely to increase the demand for the product in the forthcoming years. The observation offered by Market Research Future (MRFR) reveals that the global ureteral stents market is set to expand at a CAGR of 8% across the review period 2017 to 2023.

Also Read : https://www.medgadget.com/2019/07/ureteral-stents-market-is-set-to-expand-at-a-cagr-of-8-across-globe-by-2019-to-2023-allium-medical-solutions-ltd-medline-industries-pnn-medical-a-s-applied-medical-etc.html

The increasing population of patients having diabetes is one of the crucial factors responsible for the development of the ureteral stents market. In addition, sedentary lifestyle and poor dietary habits are also poised to boost the patient population, thus, enabling expansion of ureteral stents market in the foreseeable future. However, the adverse effects of the stents and complications in its removal remain impediments to market growth.

Competitive Dashboard:

The landscape of the market exhibits healthy competition. Increasing investments in research & development are expected to bring innovations in the ureteral stents market in the upcoming years. Technological innovations are likely to pave the way for new entrants, thus supporting the expansion of the market over the next couple of years.

Cook Medical, Inc. (US), Boston Scientific Corporation (US), C. R. Bard, Inc. (US), Allium Medical Solutions Ltd (Israel), Medline Industries, Inc. (US), Pnn Medical A/S (Denmark), Applied Medical (US), Urovision (Germany), B. Barun melsungen (Germany), Coloplast (Denmark), Teleflex (US) are some of the prominent players in the global ureteral stents market profiled in this MRFR report. Other important participants of the global market are Urotech, Surgimedik Opti-Med, Goharshafa, ConMed, Mednova, W. L. Gore & Associates Inc., Micro-Tech Co., Ltd, Merit Endotek, Rontis Medical, and Smiths Medical.

Market Segmentation:

The key segments of the global ureteral stents market, on the basis of its type, are open end stents, closed end stents, double pigtail stents, and multiloop stents.

Based on the type of material, the ureteral stents market has been segmented into metal stents, plastic stents, polyurethane stents, silicone stents, hydrogel stents, and other.

The important applications identified for providing an informative insight into the ureteral stents market are lithotripsy, ureterorenoscopy, and others.

Regional Analysis:

The geographical evaluation of the global ureteral stents market spans across five regions, which are North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa (MEA). North America is expected to generate considerable revenue from the market in the forthcoming years. The key factor facilitating the expansion of the ureteral stents market in the region is the developed healthcare infrastructure that enables the adoption of new techniques and procedures. The region’s penchant for technology is anticipated to drive the expansion of the regional market in the years to come. In addition, the region is witnessing a massive increase in the population of diabetic patients. This, in turn, is projected to expedite the proliferation of the ureteral stents market in the region over the next few years.

Europe is poised to show a healthy growth pattern in the upcoming years. The region is likely to benefit from the rising number of research & development projects being carried on in the healthcare sector. Moreover, the rising investments from the governments, in conjunction with the implementation of favorable laws supporting research projects, is expected to boost the revenue creation of the participants of the ureteral stents market in the region.

Asia Pacific is expected to exhibit positive growth over the next couple of years. The region is witnessing a boom in the healthcare sector coupled with technological advancements. These factors are projected to catapult the regional ureteral stents market on upward trajectory. In addition, the rising patient population of the region is also prognosticated to favor the proliferation of the regional market in the upcoming years. Meanwhile, the growth of the healthcare sector in the developing and developed economies of the Middle East is likely to drive the expansion of the ureteral stents market in MEA.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ureteral-stents-market-1389

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Vacuum Blood Collection Tube Market Witness A Remarkable Growth Projected By 2027

An expert on premium research reports, Market Research Future has added a report titled "Global Vacuum Blood Collection Tube Market 2027" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Vacuum Blood Collection Tube Market 2020 Research Report, Size, Share, Trends and Industry Growth Analysis By Type (Gel & Clot Activator Tube, Heparin Tubes, Serum Separating Tubes, and Others), by Application (Blood Routine Examination, Others), by End-User (Hospital, Clinics, and Others) – Forecast to 2027

Also Read : https://www.medgadget.com/2020/02/vacuum-blood-collection-tube-market-size-is-expected-to-grow-at-a-cagr-11-6-by-2027-global-industry-analysis-top-key-players-size-growth-analysis-and-segments.html

Vacuum Blood Collection Tube Market Analysis

Worldwide vacuum blood collection tube market is predicted to grow at an 11.6% CAGR over the forecast period (2018-2027), states the latest Market Research Future (MRFR) report. Vacuum blood collection tube is a tube made of plastic or sterile glass that includes stoppers in generating a vacuum seal inside the collection tube. As the name suggests, the vacuum blood collection tube works on vacuum technology. It helps in preventing needle-stick damage by stopping human contact of needles, thus decreasing contamination. These tubes have double point needles which is fixed to the tubular adaptor. Vacuum blood collection tubes are mostly utilized by laboratories and clinics to store blood for future testing.

Various factors are propelling the vacuum blood collection tube market growth. Some of these factors, according to the Market Research Future report, include rising investments in vacuum blood collection devices, rising use of blood collection devices, increasing blood transfusion, burgeoning demand for reliable and safe equipment for blood collection, use of aseptic methods during patient care, and increasing awareness regarding the significance of health both in developing and developed countries. Additional factors pushing market growth include technological advancements in vacuum blood collection tubes, increasing use of combination therapy, increasing prevalence of chronic respiratory disease, and use of these tubes for diagnosis of different diseases including cardiovascular diseases, anemia, HIV, and diabetes.

On the contrary, risk related to blood transfusion, scarcity of skilled personnel, and low popularity of these tubes in undeveloped countries are factors that may restrict the vacuum blood collection tube market growth over the forecast period.

Vacuum Blood Collection Tube Market Key Players

Leading players profiled in the vacuum blood collection tube market report include Sarstedt, Medtronic (US), GBO, Terumo (Japan), Sekisui Chemical Co. Ltd, Hebei Xinle Sci &Tech Co., LTD (China), HUMAN (US), Bio – X, Labtech Disposables, CML Biotech, Narang Medical Limited, Sunphoria Co., Ltd. (Taiwan), Dickinson and Company (US), and Becton, among others. Key players are incorporating various strategies such as partnerships, expansions, product innovations and launches, mergers and acquisitions, and research and development for creating a foothold in the market.

Vacuum Blood Collection Tube Market Segmentation

The MRFR report offers a wide segmental analysis of the vacuum blood collection tube market on the basis of application, type, and end user.

Vacuum Blood Collection Tube Market, by Type

Gel & Clot Activator Tube
Heparin Tubes
EDTA Tubes
Serum Separating Tubes

Vacuum Blood Collection Tube Market, by Application

Blood Routine Examination
Biochemical Test
Coagulation Testing
Blood Segmentation Testing
Others

Vacuum Blood Collection Tube Market, by End-User

Hospitals
Clinics
Pathology Laboratories
Blood Banks
Outpatient Centers

Vacuum Blood Collection Tube Market Regional Analysis

By region, the vacuum blood collection tube market report covers the latest trends and growth opportunities across Europe, North America, the Asia Pacific, and the Middle East and Africa. Of these, North America will command the market over the forecast period. It is predicted to grow at a 5.8% CAGR. This is owing to a rise in blood testing in the region due to the prevalence of new diseases. The vacuum blood collection tubes contain additional substances which preserve blood for processing in the medical laboratory.

The global vacuum blood collection tube market in Europe is predicted to have the second-largest share in the market over the forecast period. It is predicted to grow at a 6.5% CAGR. This is owing to the use of vacuum blood collection tubes for blood culture and a special collection for detecting bacteria present in the blood.

The global vacuum blood collection tube market in the APAC region is predicted to grow at the fastest pace over the forecast period. India, as well as China, are the leading contributors in this region as they are constantly using the latest technological advancements in the healthcare facility.

The global vacuum blood collection tube market in the Middle East and Africa is predicted to have a limited yet steady growth over the forecast period. This is owing to technological advancements.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/vacuum-blood-collection-tube-market-1371

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Ovulation Test Market Expected Tremendous Growth Till 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Ovulation Test Market over the forecast period.

Ovulation Test Market Overview:

The global ovulation test market is predicted to surpass a valuation of USD 2500 million, attaining a CAGR of 4.5% during the review period (2017-2023), Market Research Future (MRFR) unveils in a detailed report.

Ovulation can be defined as a process which results in the release of eggs from the ovary. Ovulation tests detects an increase in luteinizing hormone level in the urine and helps a woman to predict when an egg is likely to release.

Also Read : https://www.medgadget.com/2019/07/ovulation-test-market-2019-2023-key-findings-industry-segments-emerging-audience-profit-regional-study-and-future-prospects.html

Competitive Dashboard:

The top players operating in the global ovulation test market include Church & Dwight Co. Inc. (U.S.), Swiss Precision Diagnostics GmbH (Switzerland), HiLin Life Products Inc. (U.S.), Prestige Brands Holdings Inc. (U.S.), Fertility Focus Limited (U.K.), Fairhaven Health LLC (U.S.) Accuquik (California), Geratherm Medical AG (Germany), Piramal Healthcare (India), and NecLife (India).

Market Potential and Pitfalls

The global Ovulation Test Market has witnessed a tectonic surge over the past few years, mainly due to the increasing development of technology-driven ovulation monitors. Technological advancements aimed at getting accurate and reliable results from ovulation kits have propelled the growth of the ovulation test market across the globe. As per the CDC, one out of every eight women across the globe is facing issues in sustaining or conceiving pregnancy due to health issues. Due to such factors, companies are introducing advanced kits which will let them monitor ovulation and pregnancy. Applications like Glow and Apple’s Reproductive Health kit enables a user to visualize, record, and aggregate a large volume of data associated with the reproductive health of a patient. With women and child health and pregnancy management gaining importance across the world, the ovulation test market is predicted to flourish in the foreseeable future.

On the contrary, low precision of ovulation predictor kits confirming ovulation and unproven accuracy of urine-based ovulation monitors in patients suffering from PCOD/PCOS is likely to restrict the growth of the market.

Ovulation Test Market Segmental Analysis:

The ovulation test market is segmented on the basis of test and end users.

By test, the ovulation test market is segmented into saliva-based test, urine-based test, and others. Of these, urine-based test acquires the largest share owing to its extensive application by women for testing pregnancy.
By end users, the ovulation test market is segmented into clinics, hospitals, fertility centers, diagnostic centers, home care, and others. Among these, home care settings are likely to gain prominence, mainly due to the declining fertility rates in men and women, increased preferences for home and remote monitoring, and rising need for constant monitoring of health conditions.

Regional Frontiers:

Geographically, the global ovulation test market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, the ovulation test market in North America is anticipated to expand at a CAGR of 2.20%, surpassing a valuation of USD 900 million by 2023. The growth can be credited to the increased awareness regarding planned pregnancy. The increased use of fertility monitoring devices for contraception is predicted to push the market growth uphill. People are highly aware of the benefits of ovulation testing through marketing campaigns, social media, and e-commerce sites. Moreover, the advent of easy-to-use fertility monitors with high accuracy is considered to propel the growth of the ovulation test market in the region.

Europe bags the second position and is likely to expand at a CAGR of 1.24% by 2023. The region will witness high growth, mainly due to the increased use of fertility monitoring devices for contraception.

The Asia Pacific will expand at the fastest rate, mainly due to the ever-increasing population in the region. The growth can be attributed to the rapidly increasing number of women suffering from lifestyle disorders. The increased investment and funding for the development of ovulation and fertility monitors are contributing to the growth of the regional market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/ovulation-test-market-1341

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Biosimilars Market Innovative Treatments, Key Methodologies, Size, Growth, Top Players Success Milestones And Forecasts To 2025

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Biosimilars Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Market Research Future published a research report on Global Biosimilars Market Reserch Report – Forecast Up To 2023. Report provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

Also Read : https://www.medgadget.com/2018/12/biosimilars-market-predicted-to-reach-26-cagr-up-to-2023-industry-share-estimation-size-expansion-new-updates-opportunities-and-challenges-by-mrfr.html

Key Players for Global Biosimilars Market

The key players in the global biosimilars market include Accord Healthcare (UK), Amgen Inc. (USA), Astra Zeneca (UK), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr. Reddy’s Laboratories Ltd. (India), Eli Lilly (USA), F. Hoffmann-La Roche Ltd. (Switzerland), Novartis (Switzerland), Pfizer Inc. (USA), Samsung Bioepis (South Korea), Sandoz International GmbH (Germany), and Teva Pharmaceuticals Industries Ltd. (Israel).

Latest Industry News

Mundipharma, a network of independent pharma companies, has acquired Spanish biosimilars development company Cinfa Biotech. The deal gives Mundipharma, access to a biosimilar to Amgen’s Neulasta (pegfilgrastim). 10 OCT 2018
The new white paper issued by the Association of European Cancer Leagues, a nonprofit, pan-European organization of national and regional cancer societies, has called for the greater use of biosimilars as a means to increase patient access to cancer treatment, and reduce costs. 10 OCT 2018

Biosimilars Market – Sketch

A Biosimilar is described as a biological, medical product which is an identical copy of the original medical product. Market Research Future (MRFR) has published and released a research report about the global biosimilars market that predicts massive enlargement for this market with 26% CAGR during the forecast period between 2016 and 2023. In terms of cash, the market has been anticipated to rise to the US $ 16.97 bn.

Analyzing the market structure, this report estimates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market. This report also covers insights on the major countries/regions in which this industry is flourishing, along with the list and description of untapped regions which could be the potential markets in the future.

The key factors aiding the growth of the global biosimilars market include clinical trial activities for biosimilars, increasing demand for the cheap medical products, increasing incident of different diseases, and strategic collaborations resulting in enhanced productivity. However, lack of awareness and physician skepticism are the major restraining factor regarding market growth.

Regional Analysis for Global Biosimilars Market

The regional segmentation of the global biosimilars market segments the market into continent-based regional markets namely Asia Pacific, North America, Europe, and rest of the world (RoW). According to the report, Europe is the biggest regional market for the biosimilars due to the advanced medical research, increasing the prevalence of diseases and rising geriatric population. Due to technological advancement, Western Europe is a bigger market than Eastern Europe. The key country-specific markets in Western Europe include France, Italy, Spain, Germany, and the United Kingdom (UK), followed by the rest of Western Europe.

North America is the second largest market, being ahead of Europe in terms of technological advancement and being equal to Europe in terms of medical research. North America‘s approach towards biosimilars is not as welcome as Europe‘s is. Major country-specific markets in North America are Canada and the United States of America (USA). The Asia Pacific has been expected to emerge as the fast-growing market during the forecast period. The country-specific markets generating maximum revenue in this region are Australia, India, Japan, South Korea, and China, followed by the rest of the Asia Pacific region.

Segments for Global Biosimilars Market

The segmentation global biosimilars market is on the basis of application, manufacturing, product, and region. The application based segmentation segments the market into blood-related disorders, immunity-related diseases, oncology, and other. Based on manufacturing, the market has contract manufacturing and in-house manufacturing. As per segmentation based on product, the market has been segmented into recombinant glycosylated proteins, recombinant non-glycosylated proteins, and others. Recombinant glycosylated proteins have been further segmented into Monoclonal antibody (mAb) and EPO. Recombinant non-glycosylated proteins have been further segmented into growth hormones, insulin, and other.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/biosimilars-market-1329

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Erectile Dysfunction Drugs Market Staggering Double Digit Cagr Driven By Advanced & Cost Effective Technologies Forecasts Till 2025

Market Research Future adds the “Erectile Dysfunction Drugs Market Research Report - Forecast to 2025” report to their unique collection.

Erectile Dysfunction Drugs Market Overview

According to Market Research Future (MRFR), the global erectile dysfunction drugs market is expected to reach a market value of USD 2930 million with a CAGR of 3.5% from 2019 to 2025 (forecast period). The report introspects the opportunities, challenges, cost structure, and recent developments pertaining to the erectile dysfunction drugs market in the report and the impact of the COVID-19 on these facets.

Also Read : https://www.medgadget.com/2020/07/erectile-dysfunction-drugs-market-worth-usd-2930-million-at-a-cagr-of-3-5-by-2025-covid-19-impact-analysis-industry-growth-size-share-swot-analysis-top-company-profile.html

Erectile dysfunction is also referred to as impotence and is characterized by an inability to build up or maintain a penile erection during sexual intercourse. Penis erection involves a hydraulic effect resulting from the entry and retention of blood into spongy bodies within the penis. Sexual arousal is responsible for the initiation of this process, indicated by the brain-to-penile nerve impulse mechanism. The causes of erectile dysfunction include adverse effects of medications, cavernosal disorders, neurogenic disorders, aging, psychological factors, multiple sclerosis and diabetes, and lifestyle changes.

Erectile Dysfunction Drugs Market Dynamics

The global market for erectile dysfunction drugs is influenced by factors such as a rising number of people suffering from this condition, a growing geriatric population, and patent expiry of the number of blockbuster drugs. In addition, an increase in the production of generic drugs combined with an increase in sedentary lifestyles and related tension is expected to drive demand growth. For example, as per the Massachusetts Male Aging Study (MMAS), the worldwide incidence of erectile dysfunction will rise from 152 million men in 1995 to 322 million in 2025. On the other hand, low patient adherence to erectile dysfunction medications is expected to impede market growth during the assessment period.

Erectile Dysfunction Drugs Market Segmentation

The global market for erectile dysfunction drugs has been segmented based on drug and end-user.

Based on drug, the global erectile dysfunction drugs market has been bifurcated into viagra (sildenafil citrate), cialis (tadalafil), stendra/spedra (avanafil), staxyn/levitra (vardenafil), vitaros (alprostadil cream), zydena (udenafil), and others. The viagra segment is expected to hold a significant market share as the first approved oral treatment for erectile dysfunction approved by the Food and Drug Administration (FDA). In 1998, Pfizer launched viagra, which dominates the market for erectile dysfunction. The Cialis segment is projected to be the fastest-growing segment because cialis offers erection for a longer period of time than viagra, cialis lasts up to 18 hours, while viagra lasts just around 4 to 6 hours.

Based on end-user, the global market for erectile dysfunction drugs has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The retail pharmacy segment is projected to be the largest market because it is readily available in retail stores. The hospital pharmacy segment is projected to be the fastest-growing segment as an increasing patient pool due to increased awareness and patient education.

Erectile Dysfunction Drugs Market Regional Analysis

By region, the global market for erectile dysfunction drugs has been divided into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas’ market is projected to dominate the global market for erectile dysfunction drugs due to the growing prevalence of erectile dysfunction and rising awareness and patient education in the area. High rates of erectile dysfunction are expected to fuel market development in the US and Canada. For example, according to the study, the average prevalence of erectile dysfunction in men over 20 years of age was 18.4%, suggesting that erectile dysfunction affects 18 million people in the US. In addition, growing expenditure on research by healthcare providers engaged in research into novel drugs is expected to push the growth of the market in this area.

The market in Europe has shown a significant amount of growth. It can be due to the growing adoption of a sedentary lifestyle and related stress in the European region.

The market in the Asia Pacific is expected to have the highest growth rate during the forecast period due to the growing geriatric population and the rising availability of generic drugs. For instance, as per the United Nations Population Fund, by 2050, 1 in 4 citizens in Asia and the Pacific would be over 60 years of age. The population of older people (over 60 years of age) in the country will increase between 2010 and 2050, reaching close to 1.3 billion. The incidence of erectile dysfunction raises with the rising age, so the Asia Pacific market will expand rapidly in the forecast period.

The market in the Middle East and Africa is expected to represent the least share of the global market due to a low level of awareness and patient education in the region.

Erectile Dysfunction Drugs Market Key Players

The leading participants in the global erectile dysfunction drugs market are Pfizer, Inc., Apricus Biosciences Inc., Bayer AG, Cristalia Produtos Quimicos Farmaceuticos Ltd., Dong-A Pharmaceutical Co. Ltd., Eli Lilly and Company, Meda Pharmaceuticals, Inc., S.K. Chemicals Co. Ltd., Vivus, Inc., Teva Pharmaceutical Industries Ltd. Major companies on the market are engaged in strategic acquisitions, collaborations, mergers, and new product launch to maintain their market position.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com